The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations? - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Expert Review of Anticancer Therapy Année : 2017

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-03623715 , version 1 (29-03-2022)

Identifiants

Citer

Anthony Gonçalves, Audrey Monneur, Patrice Viens, François Bertucci. The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?. Expert Review of Anticancer Therapy, 2017, 17 (7), pp.593-606. ⟨10.1080/14737140.2017.1330655⟩. ⟨hal-03623715⟩

Collections

CNRS UNIV-AMU CRCM
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More